Delivery Order SPE2DB20D1100-SPE2DB24FB7T7
Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,064.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,118,743 units of DEXMETHYLPHENIDATE ER 15 MG CP, a prescription medication, with a completion date of May 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,502.12, is a Delivery Order contract for the supply of DEXMETHYLPHENIDATE ER 30 MG CP 100S, a prescription medication. The contract has a ceiling value of $1,502.12 and an ultimate completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $1,381.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that provides Dexmethylphenidate ER 10 mg capsules in 100-count packages. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, valued at $3,014.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,373,469 units of DEXMETHYLPHENIDATE ER 20 MG CP, a generic pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $3,857.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,073,585 units of the drug dexmethylphenidate ER 20 mg with a completion date of April 30, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award for $3,499.20 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the supply of 4,559,544,850 units of the prescription medication dexmethylphenidate ER 10 mg capsules to support military healthcare programs. The contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,370.40 Firm Fixed Price contract is a Delivery Order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which runs through November 2026. The award covers the supply of 4,564,326,050 units of the drug DEXMETHYLPHENIDATE ER 25 MG CP. This is an open competition...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,316.37 Firm Fixed Price contract is for the delivery of DEXMETHYLPHENIDATE ER 5 MG CAP 100S, a pharmaceutical product, with a completion date of January 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,054.77, is a delivery order for the supply of 4564955007 - DEXMETHYLPHENIDATE ER 10 MG CP 100S. The award has an ultimate completion date of June 20, 2024 and a firm fixed price pricing type. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The award, valued at $2,296.62, is for the delivery of 4564559763 - DEXMETHYLPHENIDATE ER 10 MG CP 100S, a prescription medication. The contract has an ultimate completion date of May 10, 2024 and is structured as a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB7T7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,364.69, is for the delivery of DEXMETHYLPHENIDATE ER 20 MG CP 100S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 5/16/25, 12:22 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 5/14/24 |